- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: IPI-145
Total 473 results
-
SecuraBioCompletedAsthmaGermany, United Kingdom
-
SecuraBioCompleted
-
SecuraBioCompletedHepatic ImpairmentUnited States
-
SecuraBioTerminatedHematologic MalignanciesUnited States
-
SecuraBioCompletedIndolent Non-Hodgkin LymphomaBelgium, France, Italy, Spain, Canada, United States, Bulgaria, United Kingdom, Hungary, Georgia, Belarus, Czechia
-
SecuraBioCompletedHematologic MalignancyUnited States, Italy
-
AbbVieInfinity Pharmaceuticals, Inc.Completed
-
M.D. Anderson Cancer CenterInfinity Pharmaceuticals, Inc.Withdrawn
-
SecuraBioCompletedHealthy VolunteersNetherlands
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
Dana-Farber Cancer InstituteSecura Bio, Inc.RecruitingChronic Lymphocytic Leukemia | Richter SyndromeUnited States
-
SecuraBioCompletedRheumatoid ArthritisPoland, Ukraine, Mexico, Bulgaria, Romania, Serbia, New Zealand, Russian Federation, Germany, Hungary, Colombia
-
SecuraBioCompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaBelgium, France, Italy, Spain, United States, Austria, New Zealand, Hungary, United Kingdom, Australia, Germany
-
SecuraBioCompletedA Phase 3 Study of Duvelisib Versus Ofatumumab in Patients With Relapsed or Refractory CLL/SLL (DUO)Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaBelgium, France, Italy, Spain, United States, Austria, New Zealand, Hungary, Germany, United Kingdom, Australia
-
SecuraBioTerminatedLymphoma, Small Lymphocytic | Lymphocytic Leukemia, ChronicUnited States, Canada
-
SCRI Development Innovations, LLCInfinity Pharmaceuticals, Inc.CompletedStudy of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic MalignanciesLymphoma | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | T-cell LymphomaUnited States
-
Innovation Pharmaceuticals, Inc.CompletedA Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19COVID-19United States, Russian Federation
-
SecuraBioCompleted
-
SecuraBioCompleted
-
SecuraBioWithdrawnFollicular Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic Lymphoma | Indolent Non-Hodgkin's LymphomaUnited States
-
Dana-Farber Cancer InstituteSecura Bio, Inc.Active, not recruitingChronic Lymphocytic LeukemiaUnited States
-
SecuraBioTerminatedFollicular LymphomaFrance, Italy, Australia, Poland
-
Medtronic - MITGCompletedRespiratory Insufficiency | Respiratory DepressionUnited States
-
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer Institute; Stanford UniversityActive, not recruitingLymphoma | Relapsed/Refractory T-cell LymphomasUnited States
-
Emory UniversityNational Cancer Institute (NCI); Novartis; Secura Bio, Inc.RecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaUnited States
-
National Cancer Institute (NCI)RecruitingStage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8 | Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8 | Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8United States
-
David Bond, MDCompletedChronic Lymphocytic Leukemia | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Small Lymphocytic Lymphoma | Richter Syndrome | Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell... and other conditionsUnited States
-
Narendranath EpperlaWithdrawnRecurrent Marginal Zone Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory Marginal Zone Lymphoma | Refractory Nodal Marginal Zone Lymphoma | Recurrent Nodal Marginal Zone Lymphoma | Recurrent Splenic Marginal Zone Lymphoma | Refractory Splenic Marginal Zone Lymphoma and other conditions
-
SecuraBioWithdrawn
-
SecuraBioTerminatedCD20+ Follicular LymphomaBelgium, Italy, United States, Spain, United Kingdom, France
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive | Recurrent Acute Lymphoblastic Leukemia | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Refractory Acute Lymphoblastic Leukemia | Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive and other conditionsUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Infinity Pharmaceuticals, Inc.TerminatedLung Cancer | Stage IV Lung Cancer | Stage IIIb Lung CancerUnited States
-
Infinity Pharmaceuticals, Inc.CompletedGastrointestinal Stromal Tumors | Soft Tissue SarcomasUnited States, Canada
-
Jena University HospitalCompletedEffectiveness and Safety of the Seldinger Wire Technique Using a 145 cm Guidewire With the Modified Seldinger Technique Using a 70 cm GuidewireGermany
-
Infinity Pharmaceuticals, Inc.Bristol-Myers SquibbCompletedSolid Tumor | Bladder Cancer | Advanced Cancer | Urothelial CarcinomaFrance, Spain, United States, Italy, Czechia, Poland, Serbia
-
Infinity Pharmaceuticals, Inc.TerminatedMetastatic MelanomaUnited States
-
Infinity Pharmaceuticals, Inc.Completed
-
Rush University Medical CenterCompletedMechanical Ventilation Complication | ExtubationUnited States
-
Ezra CohenThe V Foundation for Cancer ResearchRecruitingHead and Neck Cancer | HPV-Related Malignancy | Head and Neck Squamous Cell Carcinoma | Head and Neck Carcinoma | HPV-Related Carcinoma | HPV-Related Squamous Cell Carcinoma | Head and Neck Cancer Stage IV | Head and Neck Cancer Stage IIIUnited States
-
Infinity Pharmaceuticals, Inc.Terminated
-
Infinity Pharmaceuticals, Inc.WithdrawnDedifferentiated LiposarcomaUnited States
-
Infinity Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Infinity Pharmaceuticals, Inc.CompletedChondrosarcoma | Basal Cell CarcinomaUnited States
-
EnsomaCompletedHealthy | Renal InsufficiencyUnited States
-
Infinity Pharmaceuticals, Inc.CompletedConventional ChondrosarcomaUnited States, Italy, Canada, Austria, Australia, Germany, France, Netherlands, Norway, Poland, Russian Federation, Sweden, United Kingdom
-
Iovance Biotherapeutics, Inc.CompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Maimonides UniversityRecruiting
-
Ensomabluebird bioTerminatedSickle Cell DiseaseUnited States
-
Northern State Medical UniversityCompletedMechanical Ventilation Complication | Postoperative Pulmonary AtelectasisRussian Federation